Engineered viruses as genome editing devices

Molecular Therapy

Volumn 24, Issue 3, 2016, Pages 447-457

  Chen, Xiaoyu ^a   Gonçalves, Manuel A F V ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; VIRUS VECTOR; ENDONUCLEASE;

ADENO ASSOCIATED VIRUS; ADENOVIRIDAE; ARTICLE; GENETIC ENGINEERING; GENETIC PROCEDURES; GENOME EDITING; HUMAN; LENTIVIRINAE; NONHUMAN; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRUS PARTICLE; ANIMAL; GENE EDITING; GENE TARGETING; GENE VECTOR; GENETICS; GENOME; METABOLISM; PROCEDURES; VIRUS;

ANIMALS; ENDONUCLEASES; GENE EDITING; GENE TARGETING; GENETIC ENGINEERING; GENETIC VECTORS; GENOME; HUMANS; VIRUSES;

EID: 84960389900     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2015.164     Document Type: Review

References (86)

1. Gaj, T, Gersbach, CA and Barbas, CF 3rd. (2013). ZFN, TALEN and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31: 397-405
2. Maggio, I and Gonçalves, MA. (2015). Genome editing at the crossroads of delivery, specificity and fidelity. Trends Biotechnol 33: 280-291
3. Kim, H and Kim, JS. (2014). A guide to genome engineering with programmable nucleases. Nat Rev Genet 15: 321-334
4. Kay, MA, Glorioso, JC and Naldini, L. (2001). Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7: 33-40
5. Gonçalves, MA. (2005). A concise peer into the background, initial thoughts and practices of human gene therapy. Bioessays 27: 506-517
6. Skipper, KA and Mikkelsen, JG. (2015). Delivering the goods for genome engineering and editing. Hum Gene Ther 26: 486-497
7. Biasco, L, Baricordi, C and Aiuti, A. (2012). Retroviral integrations in gene therapy trials. Mol Ther 20: 709-716
8. Sterneckert, JL, Reinhardt, P and Schöler, HR. (2014). Investigating human disease using stem cell models. Nat Rev Genet 15: 625-639
9. Perez, EE, Wang, J, Miller, JC, Jouvenot, Y, Kim, KA, Liu, O, et al. (2008). Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816
10. Tebas, D, Stein, WW, Tang, I, Frank, SQ, Wang, G, Lee, SK, et al. (2014). Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370: 901-910
11. Sadelain, M, Papapetrou, EP and Bushman, FD. (2012). Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer 12: 51-58
12. Mátrai, J, Chuah, MK and VandenDriessche, T. (2010). Recent advances in lentiviral vector development and applications. Mol Ther 18: 477-490
13. Naldini, L. (2011). Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet 12: 301-315
14. Philpott, NJ and Thrasher, AJ. (2007). Use of nonintegrating lentiviral vectors for gene therapy. Hum Gene Ther 18: 483-489
15. Wanisch, K and Yáñez-Muñoz, RJ. (2009). Integration-deficient lentiviral vectors: a slow coming of age. Mol Ther 17: 1316-1332
16. Cronin, J, Zhang, XY and Reiser, J. (2005). Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5: 387-398
17. Lombardo, A, Genovese, P, Beausejour, CM, Colleoni, S, Lee, YL, Kim, KA, et al. (2007). Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25: 1298-1306
18. Benabdallah, BF, Duval, A, Rousseau, J, Chapdelaine, P, Holmes, MC, Haddad, E, et al. (2013). Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation. Mol Ther Nucleic Acids 2: e68
19. Holkers, M, Maggio, I, Henriques, SF, Janssen, JM, Cathomen, T and Gonçalves, MA. (2014). Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat Methods 11: 1051-1057
20. Coluccio, A, Miselli, F, Lombardo, A, Marconi, A, Malagoli Tagliazucchi, G, Gonçalves, MA, et al. (2013). Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination. Mol Ther 21: 1695-1704
21. Rio, P, Baños, R, Lombardo, A, Quintana-Bustamante, O, Alvarez, L, Garate, Z, et al. (2014). Targeted gene therapy and cell reprogramming in Fanconi anemia. EMBO Mol Med 6: 835-848
22. Kass, EM and Jasin, M. (2010). Collaboration and competition between DNA doublestrand break repair pathways. FEBS Lett 584: 3703-3708
23. Doulatov, S, Notta, F, Laurenti, E and Dick, JE. (2012). Hematopoiesis: a human perspective. Cell Stem Cell 10: 120-136
24. Genovese, P, Schiroli, G, Escobar, G, Di Tomaso, T, Firrito, C, Calabria, A, et al. (2014). Targeted genome editing in human repopulating haematopoietic stem cells. Nature 510: 235-240
25. Hoban, MD, Cost, GJ, Mendel, MC, Romero, Z, Kaufman, ML, Joglekar, AV, et al. (2015). Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells. Blood 125: 2597-2604
26. Kumar, M, Keller, B, Makalou, N and Sutton, RE. (2001). Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 12: 1893-1905
27. Holkers, M, Maggio, I, Liu, J, Janssen, JM, Miselli, F, Mussolino, C, et al. (2013). Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res 41: e63
28. Yang, L, Guell, M, Byrne, S, Yang, JL, De Los Angeles, A, Mali, P, et al. (2013). Optimization of scarless human stem cell genome editing. Nucleic Acids Res 41: 9049-9061
29. Joglekar, AV, Hollis, RP, Kuftinec, G, Senadheera, S, Chan, R and Kohn, DB. (2013). Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus. Mol Ther 21: 1705-1717
30. Abarrategui-Pontes, C, Créneguy, A, Thinard, R, Fine, EJ, Thepenier, V, Fournier, le RL, et al. (2014). Codon swapping of zinc finger nucleases confers expression in primary cells and in vivo from a single lentiviral vector. Curr Gene Ther 14: 365-376
31. Kantor, B, Ma, H, Webster-Cyriaque, J, Monahan, PE and Kafri, T. (2009). Epigenetic activation of unintegrated HIV-1 genomes by gut-Associated short chain fatty acids and its implications for HIV infection. Proc Natl Acad Sci USA 106: 18786-18791
32. Pelascini, LP, Janssen, JM and Gonçalves, MA. (2013). Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells. Hum Gene Ther 24: 78-96
33. Joglekar, AV, Stein, L, Ho, M, Hoban, MD, Hollis, RP and Kohn, DB. (2014). Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors. Hum Gene Ther 25: 599-608
34. Pelascini, LP, Maggio, I, Liu, J, Holkers, M, Cathomen, T and Gonçalves, MA. (2013). Histone deacetylase inhibition rescues gene knockout levels achieved with integrasedefective lentiviral vectors encoding zinc-finger nucleases. Hum Gene Ther Methods 24: 399-411
35. Gonçalves, MA. (2005). Adeno-Associated virus: from defective virus to effective vector. Virol J 2: 43
36. Miller, DG, Petek, LM and Russell, DW. (2004). Adeno-Associated virus vectors integrate at chromosome breakage sites. Nat Genet 36: 767-773
37. McCarty, DM, Young, SM Jr and Samulski, RJ. (2004). Integration of adeno-Associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 38: 819-845
38. Russell, DW and Hirata, RK. (1998). Human gene targeting by viral vectors. Nat Genet 18: 325-330
39. Miller, DG, Wang, PR, Petek, LM, Hirata, RK, Sands, MS and Russell, DW. (2006). Gene targeting in vivo by adeno-Associated virus vectors. Nat Biotechnol 24: 1022-1026
40. Hirata, R, Chamberlain, J, Dong, R and Russell, DW. (2002). Targeted transgene insertion into human chromosomes by adeno-Associated virus vectors. Nat Biotechnol 20: 735-738
41. Vasileva, A and Jessberger, R. (2005). Precise hit: adeno-Associated virus in gene targeting. Nat Rev Microbiol 3: 837-847
42. Lukacsovich, T, Yang, D and Waldman, AS. (1994). Repair of a specific double-strand break generated within a mammalian chromosome by yeast endonuclease I-SceI. Nucleic Acids Res 22: 5649-5657
43. Rouet, P, Smih, F and Jasin, M. (1994). Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci USA 91: 6064-6068
44. Miller, DG, Petek, LM and Russell, DW. (2003). Human gene targeting by adenoassociated virus vectors is enhanced by DNA double-strand breaks. Mol Cell Biol 23: 3550-3557
45. Porteus, MH, Cathomen, T, Weitzman, MD and Baltimore, D. (2003). Efficient gene targeting mediated by adeno-Associated virus and DNA double-strand breaks. Mol Cell Biol 23: 3558-3565
46. Ellis, BL, Hirsch, ML, Porter, SN, Samulski, RJ and Porteus, MH. (2013). Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-Approved drugs. Gene Ther 20: 35-42
47. Händel, EM, Gellhaus, K, Khan, K, Bednarski, C, Cornu, TI, Müller-Lerch, F, et al. (2012). Versatile and efficient genome editing in human cells by combining zincfinger nucleases with adeno-Associated viral vectors. Hum Gene Ther 23: 321-329
48. Rahman, SH, Bobis-Wozowicz, S, Chatterjee, D, Gellhaus, K, Pars, K, Heilbronn, R, et al. (2013). The nontoxic cell cycle modulator indirubin augments transduction of adenoassociated viral vectors and zinc-finger nuclease-mediated gene targeting. Hum Gene Ther 24: 67-77
49. Asuri, P, Bartel, MA, Vazin, T, Jang, JH, Wong, TB and Schaffer, DV. (2012). Directed evolution of adeno-Associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells. Mol Ther 20: 329-338
50. Kotterman, MA and Schaffer, DV. (2014). Engineering adeno-Associated viruses for clinical gene therapy. Nat Rev Genet 15: 445-451
51. Gregorevic, P, Blankinship, MJ, Allen, JM, Crawford, RW, Meuse, L, Miller, DG, et al. (2004). Systemic delivery of genes to striated muscles using adeno-Associated viral vectors. Nat Med 10: 828-834
52. Gao, GP, Alvira, MR, Wang, L, Calcedo, R, Johnston, J and Wilson, JM. (2002). Novel adeno-Associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 99: 11854-11859
53. Li, H, Haurigot, V, Doyon, Y, Li, T, Wong, SY, Bhagwat, AS, et al. (2011). In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475: 217-221
54. Anguela, XM, Sharma, R, Doyon, Y, Miller, JC, Li, H, Haurigot, V, et al. (2013). Robust ZFN-mediated genome editing in adult hemophilic mice. Blood 122: 3283-3287
55. Senís, E, Fatouros, C, Grobe, S, Wiedtke, E, Niopek, D, Mueller, AK, et al. (2014). CRISPR/Cas9-mediated genome engineering: an adeno-Associated viral (AAV) vector toolbox. Biotechnol J 9: 1402-1412
56. Swiech, L, Heidenreich, M, Banerjee, A, Habib, N, Li, Y, Trombetta, J, et al. (2015). In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol 33: 102-106
57. Ran, FA, Cong, L, Yan, WX, Scott, DA, Gootenberg, JS, Kriz, AJ, et al. (2015). In vivo genome editing using Staphylococcus aureus Cas9. Nature 520: 186-191
58. Ohbayashi, F, Balamotis, MA, Kishimoto, A, Aizawa, E, Diaz, A, Hasty, P, et al. (2005). Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors. Proc Natl Acad Sci USA 102: 13628-13633
59. Liu, GH, Suzuki, K, Qu, J, Sancho-Martinez, I, Yi, F, Li, M, et al. (2011). Targeted gene correction of laminopathy-Associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8: 688-694
60. Aizawa, E, Hirabayashi, Y, Iwanaga, Y, Suzuki, K, Sakurai, K, Shimoji, M, et al. (2012). Efficient and accurate homologous recombination in hESCs and hiPSCs using helperdependent adenoviral vectors. Mol Ther 20: 424-431
61. Shayakhmetov, DM, Papayannopoulou, T, Stamatoyannopoulos, G and Lieber, A. (2000). Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J Virol 74: 2567-2583
62. Knaän-Shanzer, S, Van Der Velde, I, Havenga, MJ, Lemckert, AA, De Vries, AA and Valerio, D. (2001). Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B. Hum Gene Ther 12: 1989-2005
63. Knaän-Shanzer, S, van de Watering, MJ, van der Velde, I, Gonçalves, MA, Valerio, D and de Vries, AA. (2005). Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells 23: 1598-1607
64. Gonçalves, MA, de Vries, AA, Holkers, M, van de Watering, MJ, van der Velde, I, van Nierop, GP, et al. (2006). Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Hum Mol Genet 15: 213-221
65. Janssen, JM, Liu, J, Skokan, J, Gonçalves, MA and de Vries, AA. (2013). Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR-or CD46-positive cells. J Gene Med 15: 1-11
66. Gonçalves, MA, Holkers, M, Cudré-Mauroux, C, van Nierop, GP, Knaän-Shanzer, S, van der Velde, I, et al. (2006). Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells. Mol Ther 13: 976-986
67. Vellinga, J, Van der Heijdt, S and Hoeben, RC. (2005). The adenovirus capsid: major progress in minor proteins. J Gen Virol 86(Pt 6): 1581-1588
68. Kreppel, F and Kochanek, S. (2008). Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide. Mol Ther 16: 16-29
69. Provasi, E, Genovese, P, Lombardo, A, Magnani, Z, Liu, PQ, Reik, A, et al. (2012). Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer. Nat Med 18: 807-815
70. Li, L, Krymskaya, L, Wang, J, Henley, J, Rao, A, Cao, LF, et al. (2013). Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Mol Ther 21: 1259-1269
71. Saydaminova, K, Ye, X, Wang, H, Richter, M, Ho, M, Chen, H, et al. (2015). Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation. Mol Ther Methods Clin Dev 1: 14057
72. Maggio, I, Holkers, M, Liu, J, Janssen, JM, Chen, X and Gonçalves, MA. (2014). Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Sci Rep 4: 5105
73. Holkers, M, Cathomen, T and Gonçalves, MA. (2014). Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells. Methods 69: 179-187
74. Zhang, W, Chen, H, Zheng, X, Wang, D, Ji, H, Xia, H, et al. (2014). Targeted genome correction by a single adenoviral vector simultaneously carrying an inducible zinc finger nuclease and a donor template. J Biotechnol 188C: 1-6
75. Suzuki, K, Yu, C, Qu, J, Li, M, Yao, X, Yuan, T, et al. (2014). Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. Cell Stem Cell 15: 31-36
76. Zhang, S, Li, L, Kendrick, SL, Gerard, RD and Zhu, H. (2014). TALEN-mediated somatic mutagenesis in murine models of cancer. Cancer Res 74: 5311-5321
77. Maddalo, D, Manchado, E, Concepcion, CP, Bonetti, C, Vidigal, JA, Han, YC, et al. (2014). In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 516: 423-427
78. Cheng, R, Peng, J, Yan, Y, Cao, P, Wang, J, Qiu, C, et al. (2014). Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9. FEBS Lett 588: 3954-3958
79. Ding, Q, Strong, A, Patel, KM, Ng, SL, Gosis, BS, Regan, SN, et al. (2014). Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing. Circ Res 115: 488-492
80. Gonçalves, MA and de Vries, AA. (2006). Adenovirus: from foe to friend. Rev Med Virol 16: 167-186
81. Louis Jeune, V, Joergensen, JA, Hajjar, RJ and Weber, T. (2013). Pre-existing antiadeno-Associated virus antibodies as a challenge in AAV gene therapy. Hum Gene Ther Methods 24: 59-67
82. Mingozzi, F and High, KA. (2013). Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122: 23-36
83. Kotin, RM. (2011). Large-scale recombinant adeno-Associated virus production. Hum Mol Genet 20(R1): R2-R6
84. Duffy, S, Shackelton, LA and Holmes, EC. (2008). Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9: 267-276
85. Gabriel, R, Lombardo, A, Arens, A, Miller, JC, Genovese, P, Kaeppel, C, et al. (2011). An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 29: 816-823
86. Seregin, SS and Amalfitano, A. (2009). Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Expert Opin Biol Ther 9: 1521-1531